Patient Registry Study of Berinert® in Normal Clinical Practice

Completed

Conditions studied: Includes: Hereditary Angioedema

In brief

The objective of this patient registry is to collect data on the safety of Berinert® in normal clinical practice in the United States. The patient registry will be maintained for a period of at least 3 years. The duration of individual patient participation will vary and is determined by the frequency of hereditary angioedema (HAE) attacks and the patient's need for Berinert® treatment.

Key facts

Study ID

NCT01108848

Run by

CSL Behring

People needed

318

Starts

2010-04-01

Expected to finish

2014-04-01

Last updated by the study team

2014-06-09

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Any patient receiving CSL Behring's C1-esterase inhibitor
• Written informed consent (may not be required for some retrospective chart review cases)

You may not qualify if…

• Any patient participating in an HAE study using other C1-inhibitors than Berinert®

Where it is running

• United States, Arizona — Scottsdale, Arizona, United States
• United States, California — Granada Hills, California, United States
• United States, California — Los Angeles, California, United States
• United States, California — Redding, California, United States
• United States, California — San Diego, California, United States
• United States, Georgia — Atlanta, Georgia, United States
• United States, Idaho — Idaho Falls, Idaho, United States
• United States, Louisiana — New Orleans, Louisiana, United States
• United States, Maryland — Chevy Chase, Maryland, United States
• United States, Maryland — Columbia, Maryland, United States
• United States, Massachusetts — Boston, Massachusetts, United States
• United States, Minnesota — Plymouth, Minnesota, United States
• United States, Missouri — Kansas City, Missouri, United States
• United States, Missouri — St Louis, Missouri, United States
• United States, New Jersey — Branchburg, New Jersey, United States
• United States, New Jersey — Edison, New Jersey, United States
• United States, New Jersey — Iselin, New Jersey, United States
• United States, New Jersey — Ocean City, New Jersey, United States
• United States, New York — New York, New York, United States
• United States, New York — North Syracuse, New York, United States
• United States, North Carolina — Durham, North Carolina, United States
• United States, Ohio — Centerville, Ohio, United States
• United States, Ohio — Cincinnati, Ohio, United States
• United States, Oklahoma — Oklahoma City, Oklahoma, United States
• United States, Oklahoma — Tulsa, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.